As of Jun 23
| +0.20 / +6.64%|
The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 4.15, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +29.28% increase from the last price of 3.21.
The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.